A study published in European Urology showed that the use of stem cells, when injected into the tunica albuginea (penis), prevents fibrous formation and the degradation of elastic fibers in the corpus cavernosum, which leads to Peyronie's disease. The idea is that, in the future, this treatment can be used on patients who start the disease, i.e. in the acute phase, preventing the disease from appearing.